Malignant spinal tumors are frequently encountered in clinical practice. Most of these lesions are caused by metastatic or hematopoietic disease processes. It is useful for the practicing surgeon to have a framework for evaluating and treating these conditions. Equally important is the ability to recognize the rare patient who presents with a primary spinal malignancy, which requires a significantly different treatment protocol.